Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Vitrolife AB

Market Cap 12.02B 1.25B 1.09B 1.01B 944M 1.77B 118B 1.79B 4.68B 58.14B 4.7B 4.6B 202B P/E 2026 *
24.5x
P/E 2027 * 19.7x
Enterprise Value 12.35B 1.29B 1.12B 1.04B 970M 1.82B 121B 1.83B 4.8B 59.73B 4.83B 4.72B 208B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.13x
Free-Float
54.39%
Yield 2026 *
1.2%
Yield 2027 * 1.03%
1 day-2.53%
1 week-7.46%
Current month-10.26%
1 month-16.90%
3 months+0.91%
6 months-35.64%
Current year-35.22%
1 week 88.35
Extreme 88.35
92.9
1 month 88.35
Extreme 88.35
107.3
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 2023-07-31
Director of Finance/CFO 55 2025-10-09
Chief Investment Officer 39 -
Director TitleAgeSince
Director/Board Member 63 2013-04-18
Chairman 70 2023-07-31
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
02-05Buy

Chief Executive Officer

3,013 0.0022%
02-05Buy

Chief Operating Officer

6,470 0.0048%
02-03Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-2.53%-7.46%-35.22%-59.14% 1.25B
-2.24%-0.76%+162.17%+243.55% 17.08B
-2.46%-0.22%-44.06%-25.21% 9.08B
+2.25%+1.46%+34.11%+15.71% 6.91B
-6.28%-4.79%-36.48% - 4.89B
+1.19%-2.66%-26.79%-31.37% 4.93B
-0.86%+8.79%+104.03%+104.55% 4.5B
-5.22%+2.23%+204.72%-39.82% 4.18B
0.00%-2.73%-30.63%-32.57% 3.97B
-0.98%-5.92%-18.23%-43.36% 2.55B
Average -1.71%-1.21%+31.36%+14.70% 5.94B
Weighted average by Cap. -1.71%-0.47%+57.41%+71.16%

Financials

2026 *2027 *
Net sales 3.5B 365M 319M 295M 275M 517M 34.48B 521M 1.36B 16.95B 1.37B 1.34B 58.9B 3.77B 393M 343M 318M 296M 557M 37.14B 561M 1.47B 18.26B 1.48B 1.44B 63.43B
Net income 491M 51.15M 44.69M 41.34M 38.59M 72.44M 4.83B 72.97M 191M 2.38B 192M 188M 8.26B 610M 63.48M 55.47M 51.31M 47.89M 89.9M 6B 90.56M 237M 2.95B 238M 233M 10.25B
Net Debt 330M 34.32M 29.99M 27.74M 25.89M 48.6M 3.24B 48.96M 128M 1.59B 129M 126M 5.54B -222M -23.09M -20.18M -18.66M -17.42M -32.7M -2.18B -32.94M -86.29M -1.07B -86.69M -84.81M -3.73B
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,126
Date Price Change Volume
26-06-22 88.75 kr -2.53% 204,082
26-06-18 91.05 kr -1.67% 208,501
26-06-17 92.60 kr +0.76% 168,304
26-06-16 91.90 kr -4.17% 174,521
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
88.75SEK
Average target price
162.75SEK
Spread / Average Target
+83.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!